STOP Fentanyl Overdoses Act of 2023

Summary

Support, Treatment, and Overdose Prevention of Fentanyl Overdoses Act of 2023 or the STOP Fentanyl Overdoses Act of 2023 This bill addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances. Specifically, the bill expands surveillance of fentanyl and related substances. This includes requiring a study on how to track overdoses by type of drug (including fentanyl) and awarding grants to states for collecting data about fentanyl-involved overdoses. The bill also provides for (1) training on detecting and handling fentanyl for law enforcement, and (2) grants for forensic laboratories to facilitate surveillance of controlled substances seized by law enforcement. Additionally, the bill establishes and modifies requirements to increase access to treatment and prevention services. For example, the Bureau of Prisons must make certain services, including medication-assisted treatments, available to individuals in its custody. The bill also establishes grants and requires other efforts to expand access to medications that temporarily reverse opioid overdoses (e.g., naloxone) and related harm reduction activities. Furthermore, the bill extends, subject to some conditions, liability protections for those who administer aid in an emergency (commonly known as Good Samaritan laws) to individuals who administer opioid overdose reversal drugs and to individuals who seek medical attention for themselves or on behalf of another for a drug overdose. The bill also requires multiple reports, including a report by the Department of State on foreign sources of certain drugs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 16 May 2023

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 16 May 2023

   Introduced

   Introduced in House

   Source: IntroReferral

3. 16 May 2023

   Introduced

   Introduced in House

   Source: IntroReferral

4. 19 May 2023

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 16 May 2023 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 16 May 2023

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 16 May 2023

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 16 May 2023

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Kuster, Ann M. [D-NH-2] · D · Sponsor
• Sen. Blunt Rochester, Lisa [D-DE] · D · Sponsor
• Rep. Bacon, Don [R-NE-2] · R · Sponsor
• Rep. Tonko, Paul [D-NY-20] · D · Sponsor
• Rep. Trone, David J. [D-MD-6] · D · Sponsor
• Rep. Panetta, Jimmy [D-CA-19] · D · Sponsor
• Rep. Trahan, Lori [D-MA-3] · D · Sponsor
• Colin Allred · D · Sponsor
• Rep. Craig, Angie [D-MN-2] · D · Sponsor
• Rep. Pettersen, Brittany [D-CO-7] · D · Sponsor
• Rep. Barragán, Nanette Diaz [D-CA-44] · D · Sponsor
• Rep. Norcross, Donald [D-NJ-1] · D · Sponsor
• Rep. Cárdenas, Tony [D-CA-29] · D · Cosponsor
• Rep. Scholten, Hillary J. [D-MI-3] · D · Cosponsor
• Rep. Budzinski, Nikki [D-IL-13] · D · Cosponsor
• Rep. Casten, Sean [D-IL-6] · D · Cosponsor
• Rep. Sewell, Terri A. [D-AL-7] · D · Cosponsor
• Rep. Houlahan, Chrissy [D-PA-6] · D · Cosponsor
• Rep. Williams, Nikema [D-GA-5] · D · Cosponsor
• Rep. Pingree, Chellie [D-ME-1] · D · Cosponsor
• Rep. Keating, William R. [D-MA-9] · D · Cosponsor
• Rep. Balint, Becca [D-VT-At Large] · D · Cosponsor
• Rep. Lee, Barbara [D-CA-12] · D · Cosponsor
• Rep. Crow, Jason [D-CO-6] · D · Cosponsor
• Rep. Green, Al [D-TX-9] · D · Cosponsor
• Rep. Leger Fernandez, Teresa [D-NM-3] · D · Cosponsor
• Rep. McGarvey, Morgan [D-KY-3] · D · Cosponsor
• Rep. Stanton, Greg [D-AZ-4] · D · Cosponsor
• Rep. Thanedar, Shri [D-MI-13] · D · Cosponsor
• Rep. Salinas, Andrea [D-OR-6] · D · Cosponsor
• Rep. Horsford, Steven [D-NV-4] · D · Cosponsor
• Rep. Larsen, Rick [D-WA-2] · D · Cosponsor
• Rep. Larson, John B. [D-CT-1] · D · Cosponsor
• Rep. Ramirez, Delia C. [D-IL-3] · D · Cosponsor
• Rep. Dingell, Debbie [D-MI-6] · D · Cosponsor
• · hsif00 · Standing
• · hsju00 · Standing

Related records

• related to ← Naloxone Affordability Act of 2023